MCF Advisors’s Spectrum Pharmaceuticals Inc SPPI Stock Holding History

MCF Advisors’s Portfolio SPPI Stock Details SPPI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-70,000	Closed	-$228K	–	625
2021 Q1	$228K	Buy	+70,000	New	+$251K	0.03%	156

Other funds holding SPPI

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

ACM

Alethea Capital Management Mercer Island, Washington $195M AUM 51.17% 1-Year Est. Return

MCF Advisors's SPPI Position: Q2 2021 in Review

MCF Advisors sold out of Spectrum Pharmaceuticals Inc (SPPI) in Q2 2021, closing a stake of 70,000 shares — an estimated $228K sold.

MCF Advisors first reported a position in SPPI in Q1 2021 and held it in 1 quarter. The position peaked at $228K in Q1 2021. 156 funds tracked by Wall St. Rank hold SPPI as of Q2 2021.

MCF Advisors reported no remaining Spectrum Pharmaceuticals Inc position as of Q2 2021 after selling out during the quarter.
MCF Advisors sold 70,000 Spectrum Pharmaceuticals Inc shares in Q2 2021, an estimated $228K.
MCF Advisors first reported a position in Spectrum Pharmaceuticals Inc in Q1 2021 and held it in 1 quarter.
MCF Advisors's Spectrum Pharmaceuticals Inc position peaked at $228K in Q1 2021.
156 funds tracked by Wall St. Rank held Spectrum Pharmaceuticals Inc as of Q2 2021.

Based on MCF Advisors's 13F filing for Q2 2021, filed 10 Aug 2021.